Eugia Pharma receives USFDA approval for Vasopressin Injection USP
The approved product has an estimated market size of around US$ 606 million for the twelve months ending June 2022, according to IQVIA.
The approved product has an estimated market size of around US$ 606 million for the twelve months ending June 2022, according to IQVIA.
Lacosamide Injection is used to treat partial-onset seizures.
Silo enters into commercial evaluation license agreement for next generation liposomes
Both manufacturing facilities are based out of Benguluru, India
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
Includes thermostabilized Ebola vaccines
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
        Subscribe To Our Newsletter & Stay Updated